The Humble Organization
This post was written following the September 28, 2017 iJOBS event with Regeneron Regeneron prides itself for being a company thriving on quality research and the active role it plays in the entire life cycle of its drugs. The company was found by two M.D Ph.Ds (Leonard S. Schleifer and George D. Yancopoulos) with the goal of creating regenerative medicine for neuroscience research. The company, which initially received $1 million in venture capital funding, now has over 5,500 employees and 6 FDA-approved drugs, which were all invented in-house, from start to finish.

This past February, nearly fifty graduate students and post-docs braved the winter weather and attended a four day long workshop called SciPhD to learn how to frame skills gained in academia to be marketable towards careers in industry.